Prelude Capital Management, LLC Viatris Inc Call Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $485,595 - $762,300	49,500 Added 32.89%	200,000 $2.18 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $2,418 - $2,936	200 Added 0.13%	150,500 $2.04 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $1.95 Million - $2.43 Million	150,300 New	150,300 $2.15 Million
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $839,862 - $1.15 Million	-61,800 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $883,740 - $1.16 Million	61,800 New	61,800 $1.16 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.